Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma.

MLA

Wurster, K. D., et al. “Inactivation of the Putative Ubiquitin-E3 Ligase PDLIM2 in Classical Hodgkin and Anaplastic Large Cell Lymphoma.” Leukemia, vol. 31, no. 3, Mar. 2017, pp. 602–13. EBSCOhost, https://doi.org/10.1038/leu.2016.238.

APA

Wurster, K. D., Hummel, F., Richter, J., Giefing, M., Hartmann, S., Hansmann, M.-L., Kreher, S., Köchert, K., Krappmann, D., Klapper, W., Hummel, M., Wenzel, S.-S., Lenz, G., Janz, M., Dörken, B., Siebert, R., & Mathas, S. (2017). Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma. Leukemia, 31(3), 602–613. https://doi.org/10.1038/leu.2016.238

Chicago

Wurster, K D, F Hummel, J Richter, M Giefing, S Hartmann, M-L Hansmann, S Kreher, et al. 2017. “Inactivation of the Putative Ubiquitin-E3 Ligase PDLIM2 in Classical Hodgkin and Anaplastic Large Cell Lymphoma.” Leukemia 31 (3): 602–13. doi:10.1038/leu.2016.238.